drugset / Trial / NCT00192712
Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study hypothesis is that chemoradiation based on 2 drugs will improve local control and long-term survival in patients with locally advanced pancreatic cancer. That is why gemcitabine and irinotecan are combined in an induction phase of 2 months and then this IrinoGem combination is given for 3 more cycles, in reduced doses,concurently with irradiation.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Irinotecan | Small molecule | — | — |